Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: DewDiligence_on_SI who wrote (3233)	2/22/2014 8:39:30 PM
From: tejek	Respond to of 4474

I don’t think it’s personal. Feuerstein tends to write in black and white rather than shades of gray—it’s an easier style for the masses to comprehend and it generates more heated discussion, which is good for (Feuerstein’s) business. Moreover, Feuerstein’s criticism of Berger is valid insofar as there are numerous documented examples where Berger was dishonest with shareholders. In my opinion, whatever success ARIA has had from an investment standpoint has come in spite of Berger, not because of him. Feuerstein’s recent tweets about PRAN are a case in point. Just read the PRAN dialogue...........I see what you mean but with '113 he's more dismissive rather than trashing it outright like he does PRAN. I guess there are some nuances to his critiques.